Cargando…

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer

Disruption of KDM6A, a histone lysine demethylase, is one of the most common somatic alternations in bladder cancer. Insights into how KDM6A mutations affect the epigenetic landscape to promote carcinogenesis could help reveal potential new treatment approaches. Here, we demonstrated that KDM6A loss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Hong, Makarov, Vladimir, Bolzenius, Jennifer K., Halstead, Angela, Parker, Yvonne, Wang, Allen, Iyer, Gopakumar V., Wise, Hannah, Kim, Daniel, Thayaparan, Varna, Lindner, Daniel J., Haber, Georges-Pascal, Ting, Angela H., Ren, Bing, Chan, Timothy A., Arora, Vivek, Solit, David B., Lee, Byron H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Genome and Epigenome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015223/ https://www.ncbi.nlm.nih.gov/pubmed/36638328 http://dx.doi.org/10.1158/0008-5472.CAN-22-1444

Ejemplares similares

CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies
por: Jiang, Long, et al.
Publicado: (2022)

Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme
por: Lopes-Ramos, Camila M., et al.
Publicado: (2021)

SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia
por: Chambers, Courtney, et al.
Publicado: (2023)

Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer
por: Nair, Viswam S., et al.
Publicado: (2022)

Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort
por: Liu, Yanhong, et al.
Publicado: (2023)

Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing
por: Sayed, Shady, et al.
Publicado: (2022)

Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer
por: Hua, Xu, et al.
Publicado: (2023)

Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
por: Yao, Lijun, et al.
Publicado: (2023)

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
por: Sjöström, Martin, et al.
Publicado: (2022)

PAX9 Determines Epigenetic State Transition and Cell Fate in Cancer
por: Zhao, Zibo, et al.
Publicado: (2021)

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
por: Patel, Monal, et al.
Publicado: (2021)

Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival
por: Gillani, Riaz, et al.
Publicado: (2021)

Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
por: Hong, Wei, et al.
Publicado: (2022)

Association of Genetic Ancestry and Molecular Signatures with Cancer Survival Disparities: A Pan-Cancer Analysis
por: Lee, Kara Keun, et al.
Publicado: (2022)

Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
por: Patel, Achal, et al.
Publicado: (2022)

Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma
por: Sen, Arko, et al.
Publicado: (2022)

Antisense RNAs Influence Promoter Usage of Their Counterpart Sense Genes in Cancer
por: Bellido Molias, Fernando, et al.
Publicado: (2021)

Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial–Mesenchymal Transition Subtypes Associated with Survival
por: Jun, Yukyung, et al.
Publicado: (2022)

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer
por: Xu, Ying, et al.
Publicado: (2022)

FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits
por: Tsai, Jessica W., et al.
Publicado: (2022)

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response
por: Berchuck, Jacob E., et al.
Publicado: (2022)

Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms
por: Belleau, Pascal, et al.
Publicado: (2023)

Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers
por: Guo, Jintao, et al.
Publicado: (2021)

Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer
por: Distefano, Rosario, et al.
Publicado: (2022)

Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer
por: Wang, Yicheng, et al.
Publicado: (2022)

Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer
por: Zhao, Xiaoyu, et al.
Publicado: (2021)

Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
por: Yu, Zhenyuan, et al.
Publicado: (2023)

DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
por: Gallon, John, et al.
Publicado: (2023)

G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
por: Zhang, Rongxin, et al.
Publicado: (2023)

Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation
por: Halstead, Angela M, et al.
Publicado: (2017)

Contingencies of UTX/KDM6A Action in Urothelial Carcinoma
por: Lang, Alexander, et al.
Publicado: (2019)

METB-08. GENOMIC AND MOLECULAR PROFILING OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: A SINGLE INSTITUTION ANALYSIS
por: Kline, Cassie, et al.
Publicado: (2023)

METB-09. GERMLINE PATHOGENIC VARIANTS IN 838 PEDIATRIC BRAIN TUMOR PATIENTS
por: McQuaid, Shelly W, et al.
Publicado: (2023)

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
por: Teo, Min Yuen, et al.
Publicado: (2021)

METB-06. HIGH FREQUENCY OF CLINICALLY RELEVANT ALTERATIONS DETECTED BY INTEGRATED TUMOR AND GERMLINE GENE PANEL TESTING IN CHILDREN WITH CNS TUMORS – RESULTS FROM THE TEXAS KIDSCANSEQ STUDY
por: Lin, Frank Y, et al.
Publicado: (2023)

Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines
por: Lang, Alexander, et al.
Publicado: (2020)

METB-04. THE MOLECULAR CHARACTERIZATION INITIATIVE (MCI): A CLINICAL AND GENOMIC RESOURCE FOR THE PEDIATRIC BRAIN TUMOR COMMUNITY
por: Leary, Sarah, et al.
Publicado: (2023)

METB-05. NON-INVASIVE DIAGNOSIS OF BRAINSTEM GLIOMAS IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT PATIENTS THROUGH CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING
por: Hill, Katherine, et al.
Publicado: (2023)

METB-11. EXPANSION OF THE PEDIATRIC BRAIN TUMOR ATLAS: AN OPEN SCIENCE EFFORT OF CHILDREN’S BRAIN TUMOR NETWORK, KIDS FIRST DATA RESOURCE AND CHILDHOOD CANCER DATA INITIATIVE
por: Koptyra, Mateusz, et al.
Publicado: (2023)

METB-07. MINIMALLY-INVASIVE DIAGNOSIS OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) USING CEREBROSPINAL FLUID CELL-FREE DNA SEQUENCING IN PEDIATRIC AND YOUNG ADULT PATIENTS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8vnhgf9ueosqen2cmqamip279